CTRI/2023/08/056292招募中3 期
To study the efficacy and safety of injectable platelet rich fibrin in androgenetic alopecia- An interventional study - NI
Dr Sahana N C0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Patients willing to give informed consent
- •2. Patients of either gender aged 18 to 60 years.
- •3. Androgenetic Alopecia in males with Norwood-Hamilton grade 2-6 and females beyond grade 1 according to Ludwigâ??s scale.
- •4. Patients willing for follow up.
排除标准
- •1. patients with Alopecia other than Androgenetic Alopecia
- •2. Patients with active infection at the local site
- •3. Patients with keloidal tendency
- •4. Patients with blood coagulopathies and platelets count below 1,50,000cell/mm3
- •5. Pregnant and lactating mothers.
研究者
相似试验
尚未招募
不适用
A comparative study of evaluation of effect of injectable platelet rich fibrin with resorbable collagen membrane to resorbable collagen membrane alone for gingival recession coverage.CTRI/2020/06/026141SCB Dental College and Hospital Cuttack
已完成
不适用
Evaluation of the efficacy, safety and injection interval of intravitreal injection of aflibercept for branch retinal vein occlusiobranch retinal vein occlusionJPRN-UMIN000018999Department of Ophthalmology, Shiga University of Medical Science40
已完成
不适用
Evaluation of the efficacy, safety and injection interval of intravitreal injection of aflibercept for age-related macular degeneratioage-related macular degenerationJPRN-UMIN000019028Department of Ophthalmology, Shiga University of Medical Science40
已完成
不适用
Evaluation of the efficacy, safety and injection interval of intravitreal injection of ranibizumab for retinal vein occlusioretinal vein occlusionJPRN-UMIN000012038Department of Ophthalmology, Shiga University of Medical Science50
已完成
不适用
Evaluation of the efficacy, safety and injection interval of intravitreal injection of aflibercept for central retinal vein occlusiocentral retinal vein occlusionJPRN-UMIN000013405Department of Ophthalmology, Shiga University of Medical Science50